Long-read sequencing reveals new details of Bartter syndrome type 3

CHICAGO — A bumetanide nasal spray in development for heart failure was well-tolerated and showed reliable rates of absorption compared with oral and intravenous delivery

About half of old­er peo­ple liv­ing with Alzheimer’s dis­ease will de­vel­op ag­i­ta­tion, man­i­fest­ed in ways such as ver­bal or phys­i­cal ag­gres­sion or rest­less­ness. But it’s

Eli Lil­ly said its weight loss ti­tan tirzepatide helped peo­ple lose up to 26% of their body weight, on av­er­age, across two late-stage clin­i­cal tri­als